Specifically, preclinical studies suggest that an increased expression of FKBP5 in several brain regions is associated with decreased stress coping, increased stress responsiveness, increased anxiety, and impaired fear extinction, all traits associated with vulnerability to psychiatric disorders (see for review [4,10]). Here, FKBP5 is linked to psychiatric disorder.